Ethyl isocyanate → 3-ethylcarbamoyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7-sulfonamide

HRID 2398168ノート

反応式

HRID 2398168 の反応式
[CH2:1]1[C:7]2[CH:8]=[CH:9][C:10]([S:12]([NH2:15])(=[O:14])=[O:13])=[CH:11][C:6]=2[CH2:5][CH2:4][NH:3][CH2:2]1.[CH2:16]([N:18]=[C:19]=[O:20])[CH3:17]>CN(C)C=O>[CH2:16]([NH:18][C:19]([N:3]1[CH2:2][CH2:1][C:7]2[CH:8]=[CH:9][C:10]([S:12]([NH2:15])(=[O:14])=[O:13])=[CH:11][C:6]=2[CH2:5][CH2:4]1)=[O:20])[CH3:17]

参加物

4

反応物 2

HCID 8022Ethyl isocyanateHCID 212429322,3,4,5-tetrahydro-1H-3-benzazepine-7-sulfonamide

生成物 1

HCID 214344333-ethylcarbamoyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7-sulfonamide

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒

実験手順

3.4 G. of 2,3,4,5-tetrahydro-1H-3-benzazepine-7-sulfonamide are dissolved in 50 ml. of dimethylformamide while warming at 60° C. and the solution is then rapidly cooled with an icebath. As soon as a temperature of 20° C. is reached, 1.18 ml. of ethylisocyanate are added dropwise while stirring, and the mixture is subsequently stirred at 25° C. for 0.5 hour. The solution is then concentrated in vacuo on a bath at 80° C. and the crystalline residue is digested with ether. There is obtained 3-ethylcarbamoyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7-sulfonamide.

後処理

  1. temperaturethe solution is then rapidly cooled with an icebath
  2. customsoon as a temperature of 20° C.
  3. stirringthe mixture is subsequently stirred at 25° C. for 0.5 hour
  4. concentrationThe solution is then concentrated in vacuo on a bath at 80° C.

出典と根拠

ORDレコード
ord-e22027093965495ba34ddd7fe695f6cd
出典データセット
uspto-grants-1977_05
特許番号
US04024128

反応ノート

読み込み中…